Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Lung Neoplasms 12Head and Neck Neoplasms 10Rectal Neoplasms 8Prostatic Neoplasms 7Mouth Neoplasms 5Glioblastoma 5Esophageal Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Ovarian Neoplasms 3Neuroblastoma 3Neoplasms 3Laryngeal Neoplasms 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Turcot syndrome 2Tongue Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2

Interventions

Paclitaxel 134Carboplatin 129Bevacizumab 86Gemcitabine 45pembrolizumab 37olaparib 33Cisplatin 30liposomal doxorubicin 29Docetaxel 29Cyclophosphamide 29Topotecan 28niraparib 27Taxes 20Etoposide 18Filgrastim 16Doxorubicin 16Immunoglobulin G 15Disulfides 15apatinib 12Letrozole 12Albumin-Bound Paclitaxel 12Drug Therapy 11fluzoparib 10fludarabine 10Specimen Handling 10Magnetic Resonance Spectroscopy 10Biopsy 10durvalumab 9Nivolumab 9pazopanib 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Ovarian Neoplasms × Celecoxib × Clear all
NCT01175772 2015-06-23

Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy

HaEmek Medical Center, Israel

Phase 2 Terminated
6 enrolled
Gynecologic

Carcinoma, Ovarian Neoplasms

NCT00084448 2013-07-09

Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer

GOG Foundation

Phase 2 Terminated
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01124435 2010-06-04

carbo-cox2

Catholic University of the Sacred Heart

Phase 2 Completed
45 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡